Systemic amyloidosis from A (AA) to T (ATTR): a review
Eli Muchtar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Francis K. Buadi, Nelson Leung(WinnMed), Shaji Kumar(Mayo Clinic), Angela Dispenzieri(Mayo Clinic), Michelle L. Mauermann(Anna Needs Neuroblastoma Answers), Ellen D. McPhail(Mayo Clinic), Martha Grogan(Mayo Clinic in Arizona), Paul J. Kurtin(Mayo Clinic), Hila Magen(Sheba Medical Center), David Dingli
Cited by 329
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k